News from SGC

Posted on Wednesday 10th of January 2024

[Toronto, January 10, 2024] - Professor Benjamin Haibe-Kains has joined the Structural Genomics Consortium as the Head of Data Science to further support SGC’s ambition to generate high-quality and reproducible data. In his new role, Dr. Haibe-Kains will establish a robust mechanism to ensure transparency, interoperability, and accessibility of SGC’s data for machine learning and pattern recognition.

Posted on Monday 20th of November 2023

The Cilla Weigelt Awards for 2022 and 2023 were recently presented at the Chiesi premises on the Karolinska Institutet campus, honoring outstanding achievements in rare disease research. Established in memory of Dr. Cilla Weigelt, the Cilla Weigelt Award aims to encourage and support doctoral students at Swedish universities focusing on identifying molecular mechanisms relevant to rare and under-treated diseases.

Posted on Thursday 16th of November 2023

Cheryl Arrowsmith, Chief Scientist of the Structural Genomics Consortium (SGC), Senior Scientist at the Princess Margaret Cancer Centre, and Professor at the Department of Medical Biophysics at the University of Toronto, has been honoured by Clarivate as one of the Highly Cited Researchers for 2023.

Posted on Friday 27th of October 2023

Government General Mary Simon has announced 53 new Order of Canada appointments- one of Canada’s highest honours. This prestigious recognition celebrates individuals from diverse backgrounds for their outstanding contributions to Canada.

Established in 1067, the Order of Canada acknowledges remarkable achievements, dedication to the community and service to the nation, with over 7,600 people spanning various sectors invested in making a difference in Canada.

Posted on Thursday 28th of September 2023

TORONTO, Canada, October 3, 2023 – The Structural Genomics Consortium (SGC) today announced that it has entered into a partnership with Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH).  HitGen will utilize its DNA-encoded library (DEL) technology platform, specifically OpenDEL™, to screen under-represented targets chosen by SGC.

Posted on Tuesday 18th of July 2023

At Structural Genomics Consortium, we are committed to driving advancements in basic and biomedical research that can positively impact the world. We believe that collaborative efforts and innovative solutions are essential for achieving groundbreaking discoveries. Today, we invite researchers from all corners of the globe to stand united in support of renewable antibody resources.

Sign the Petition to Prioritize Renewable Antibody Resources!

Have you ever experienced any of the following research roadblocks?

1.       Wasted resources on a commercial antibody that did not perform as claimed?

Posted on Friday 9th of June 2023

Let's continue to collaborate and push the boundaries to open science together! 

Posted on Wednesday 24th of May 2023

Trainees are an integral part of the 20 years SGC global network of over 250 scientists. Since 2015, we've proudly partnered with Mitacs, offering over 550 internship units to trainees across 25+ unique projects, totaling $8.4M. This direct support funds trainee stipends and research costs.

Posted on Wednesday 10th of May 2023

North Carolina, May 10, 2023 – The Structural Genomics Consortium (SGC) at the University of North Carolina at Chapel Hill has been awarded a $1.5 million grant from the U.S Department of Defense to support drug discovery efforts aimed at the investigation of small molecules that could potentially serve as new treatment options for patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease.


Subscribe to News from SGC
glqxz9283 sfy39587stf02 mnesdcuix8